ask="N/A"
ask_size="N/A"
average_daily_volume="24655"
bid="N/A"
bid_size="N/A"
book_value="0.452"
change="+0.105"
change_from_200_day_moving_average="0.388"
change_from_50_day_moving_average="0.424"
change_from_52_week_high="-1.235"
change_From_52_week_low="2.285"
change_in_percent="+2.658%"
close="4.055"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.443"
ebitda="-14.69M"
eps_estimate_current_year="-1.690"
eps_estimate_next_quarter="-0.020"
eps_estimate_next_year="-0.250"
ex_dividend_date="N/A"
float_shares="4889000"
high="4.100"
high_52_weeks="5.290"
last_trade_date="2/8/2017"
last_trade_price="4.055"
last_trade_size="400"
last_trade_time="4:02pm"
low="3.950"
low_52_weeks="1.770"
market_capitalization="61.37M"
moving_average_200_day="3.667"
moving_average_50_day="3.631"
name="NovaBay Pharmaceuticals
Inc. C"
notes="N/A"
one_year_target_price="6.750"
open="3.950"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+10.578%"
percent_change_from_50_day_moving_average="+11.671%"
percent_change_from_52_week_high="-23.346%"
percent_change_from_52_week_low="+129.096%"
previous_close="3.950"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.739"
price_per_sales="6.323"
revenue="9.45M"
shares_outstanding="15134000"
short_ratio="6.070"
stock_exchange="ASE"
symbol="NBY"
volume="28802"
weeks_range_52="1.770 - 5.290"
